• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Antibiotic Resistance Companies

    ID: MRFR/Pharma/7107-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    Antibiotic resistance occurs when bacteria or other microorganisms develop the ability to resist the effects of antibiotics, making infections harder to treat and increasing the risk of spread to others. Several companies are actively involved in addressing antibiotic resistance through the development of new antibiotics, diagnostic tools, and strategies to combat drug-resistant infections.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Antibiotic Resistance Market Research Report - Global Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Antibiotic Resistance Market

    Antibiotic Resistance Key CompaniesLatest Antibiotic Resistance Companies Update

    November 2023: Glox pharmaceuticals, a biotechnology firm specializing in the advancement of precision antibiotic medicines, has successfully secured a seed investment round amounting to USD 4.5 million. The primary objective of this money is to facilitate the development of highly efficient targeted pharmaceuticals specifically designed to combat antibiotic-resistant bacteria. The recently established company is at the forefront of developing advanced antibiotic treatments that utilize naturally occurring bacteriocins to specifically target highly resistant and potentially more harmful 'gram-negative' bacteria. The allocated funds will be utilized to create facilities in Oxford and Glasgow, as well as to augment the existing research team. Antimicrobial resistance (AMR) is responsible for an approximate annual loss of 1.27 million lives globally, as a result of the ineffectiveness of currently available medicines in treating infections.


    July 2023: EMPE Diagnostics introduced the mfloDx MDR-TB test kit, which is a unique and pioneering diagnostic tool. This test kit utilizes a combination of molecular and sensitive lateral flow biosensors to effectively detect the presence of tuberculosis (TB) bacteria and accurately identify antibiotic resistance. Notably, this test kit is the first of its kind globally. Furthermore, it is capable of delivering results within a timeframe of less than three hours, making it particularly suitable for implementation in clinics with limited resources. It is a source of great satisfaction that the development and manufacturing of the product took place within the Genome Valley, a location of significance. The mfloDx MDR-TB kit is a cost-effective and efficient diagnostic tool that offers prompt and precise results pertaining to the bacteria and its resistance characteristics.List of Antibiotic Resistance Key companies in the market

    • Achaogen Inc. (US)


    • Basilea Pharmaceutica Ltd. (Switzerland)


    • MELINTA THERAPEUTICS INC. (US)


    • PARATEK therapeutics (US)


    • Seres Therapeutics (US)


    • Theravance Biopharma (UK)


    • Entasis Therapeutics (US)


    • Tetraphase Pharmaceuticals (US)


    • Nabriva Therapeutics plc (Ireland)


    • NEMESIS BIOSCIENCE LTD (UK)